EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
30 hedge funds and large institutions have $51.1M invested in Eiger BioPharmaceuticals, Inc. in 2016 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
50% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 20
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $47K
Holders
30
Holding in Top 10
1
Calls
–
Puts
$47K
Top Buyers
| 1 | +$4.89M | |
| 2 | +$4.35M | |
| 3 | +$2.47M | |
| 4 |
PA
Perceptive Advisors
New York
|
+$1.76M |
| 5 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
+$706K |
Top Sellers
| 1 | -$142K | |
| 2 | -$125K | |
| 3 | -$111K | |
| 4 |
Millennium Management
New York
|
-$103K |
| 5 |
Bank of New York Mellon
New York
|
-$91K |